Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
What Mood Symptoms may be most Difficult to Rate?
1
x
$
30.00
Gender and Schizophrenia
1
x
$
30.00
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
1
x
$
30.00
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Alisa B. Busch - Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
1
x
$
30.00
Zonisamide for Bipolar Depression by Deborah Dauphinais
1
x
$
30.00
Atomoxetine Induced Hypothermia by Onat Yilmaz
1
x
$
30.00
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
1
x
$
0.00
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
1
x
$
30.00
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
1
x
$
30.00
Long Acting Risperidone in an Adolescent - Mustafa Deniz Tutkunkardas
1
x
$
30.00
View Cart
Checkout
Home
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
“Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas” has been added to your cart.
View cart
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
$
30.00
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 2 Articles
Tags:
adas-cognitive-subsection-adas-cog
,
alzheimers-disease
,
alzheimers-disease-assessment-scale-adas
,
cognitive-dysfunction
,
consortium-to-establish-a-registry-for-alzheimers-disease-cerad
,
huixing-yuan
,
k-ranga-rama-krishnan
,
keith-m-gregg
,
matthias-c-kurth
,
medworks-media
,
mini-mental-status-exam-mmse
,
psychopharmacology-bulletin
,
thomas-e-gillen
Description
Description
Thomas E. Gillen, MD, MS
GENERAL PSYCHOPHARMACOLOGY
Clinical Trials in Alzheimer’s Disease
Thomas E. Gillen,MD, MS, Keith M. Gregg, PhD, Huixing Yuan, PhD, Matthias C. Kurth, MD, PhD, and K. Ranga Krishnan, MB, ChB
Related products
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Atomoxetine Induced Hypothermia by Onat Yilmaz
$
30.00
Add to cart
Details
Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality
$
30.00
Add to cart
Details
Page load link
Go to Top
